---
title: Executive Summary of the American Radium Society Appropriate Use Criteria for
  Brain Metastases in EGFR-mutated and ALK-fusion Non-Small Cell Lung Cancer
date: '2024-03-09'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38459978/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&fc=20220923065203&ff=20240310181156&v=2.18.0.post9+e462414
source: (((leukemia) OR (lymphoma)) OR (myeloma)) AND (Stanford University[Affiliation])
description: 'CONCLUSIONS: We identified no definitive studies dictating optimal sequencing
  of TKIs and RT for EGFRm and ALK+ BrM. Until such studies are completed, the committee
  hopes these cases guide decision-making in this complex clinical ...'
disable_comments: true
---
CONCLUSIONS: We identified no definitive studies dictating optimal sequencing of TKIs and RT for EGFRm and ALK+ BrM. Until such studies are completed, the committee hopes these cases guide decision-making in this complex clinical ...